Unichem Laboratories

ACASIA represents the International Business Division (IBD) of Unichem Laboratories comprising key geographies like Africa, CIS and Asia. Unichem’s strategy in ACASIA is to focus on high value added generics by leveraging its core competencies.

Unichem’s foray into the Americas includes the USA, Canada, Brazil and other Latin American markets, where the company aspires to become a major player by offering high quality and cost-effective generic products. The majority of the company’s products are vertically integrated. Unichem’s R&D team is actively developing a robust pipeline of Active Pharmaceutical Ingredients (APIs) and ANDAs to support the Company’s ambitious growth plans.

Ipca Laboratories has taken full ownership of Unichem Laboratories Ireland by acquiring 100% of its paid-up equity share capital. The transaction consolidates Ipca’s presence in the Irish pharmaceutical distribution market. The move follows Ipca’s strategic expansion into European healthcare logistics.

May 2025Capital MarketNews article

Ipca Laboratories acquires a **19.29% stake** in Unichem via an open offer. The transaction expands Ipca’s presence in the pharmaceutical distribution sector. Unichem operates as a key player in India’s retail pharmacy market.

Sep 2023business-standard.comNews article

Ipca Laboratories acquires a 19.29% stake in Unichem Laboratories, consolidating ownership and making it a subsidiary. The deal involves purchasing 135.8 million shares at Rs 440 each, totaling Rs 597.5 crore. This move strengthens Ipca’s control over Unichem’s operations and resources.

Sep 2023Free Press JournalNews article

Unichem Labs announces Dr Prakash Amrut Mody has resigned as Managing Director. The company appoints Pabitrakumar Kalipada Bhattacharyya to replace him in the role. The transition follows a BSE filing.

Aug 2023medicaldialogues.inNews article